YOU ARE HERE >> Project / Personnel / Advisors
Project
 Personnel/advisors
For those who wish to help the Project, a registered charity has been set up to fund research in this area and on-line donations can be made.
Can't find what you want?

Advisors
James C Callaway, PhD
Department of Pharmaceutical Chemistry, University of Kuopio, Finland

Dr. Callaway has a background in organic synthesis and the analytical chemistry of natural products, and is currently Adjunct Professor of Ethnopharmacology at the University of Kuopio, Finland. He is also Director of Finola, a hemp seed food company, and co-originator of FIN-314, the early-blooming Cannabis variety licensed internationally for the production of food oil and protein.
Robert Clarke Chief Botanist, Hortapharm BV, Amsterdam
Mr Clarke is an expert in the botany of the cannabis plant and is the author of two books on the subject "Marijuana Botany" and "Hashish!"
Dr. Ir. Etienne de Meijer Plant Breeder, HortaPharm B.V., Amsterdam
Dr. de Meijer is an expert in the genetic variation and breeding of cannabis. After graduation from the Wageningen Agricultural University, he established and evaluated a large cannabis germplasm collection at the Centre for Genetic Resources of the Netherlands and gained his Ph.D. with a thesis entitled "Diversity in Cannabis". He is the author of several articles on the sub-classification of the cannabis gene-pool and on the variability of cannabis for traits such as stem quality, cannabinoid profile and host-suitability for nematodes. He is currently developing selected progenies with various desired cannabinoid profiles on behalf of GW Pharmaceuticals.
Lester Grinspoon, MD
Associate Professor of Psychiatry, Harvard Medical School

Dr Grinspoon is a practising psychiatrist and served for 30 years as Senior Psychiatrist at the Massachusetts Mental Health Center in Boston. He is Editor of the Harvard Mental Health Letter as well as a Fellow of both the American Association for the Advancement of Science and the American Psychiatric Association. Dr Grinspoon was the founding editor of both the Annual Review of Psychiatry and the Harvard Mental Health Letter. He is the author or coauthor of over 150 journal articles or chapters and 12 books.

Illicit drugs have been a major area of interest for Dr Grinspoon and in 1990 he won the Alfred R. Lindesmith Award of the Drug Policy Foundation for "achievement in the field of drug scholarship." His first book, originally published in 1971, was recently republished as a classic.

John McPartland, DO, MS
Clinical Assistant Professor, Department of Family Practice, University of Vermont

Professor McPartland has served as a biocontrol consultant for many organis vegetable farms, apple orchards and cultivators of medicinal plants in the USA, Europe and India. He is the author of a number of medical publications concerning Cannabis, Phyllanthus amarus, Silybum marianum, Serenoa repens, Panax species and psychotropic mushrooms. Professor McPartland is currently seeking a grand synthesis of organic agriculture and holistic health with Cannabis as the linchpin.

Neil M. Montgomery MSc, FRSA, FRAI
Consultant Anthropologist to the UK Medicinal Cannabis Research Project

Neil Montgomery is a Fellow of The Royal Society of Arts and of The Royal Anthropological Institute. He is also a Member of the International Cannabinoid Research Society

Neil Montgomery is a Social Anthropologist specialising in the relationships between individuals, society and the cannabis plant. He has considerable experience as an Expert Witness in the Sheriff Courts and High Courts of Scotland and the Crown Courts in England, being employed principally, but not exclusively, in cultivation cases. Taking a keen interest in patterns of consumption, his research into purity and dosage was of particular interest to the House of Lords and his practicable categorisation of consumption levels has since been widely adopted.

Dr William Notcutt,MB,ChB,FRCA
Consultant in Anaesthesia and Pain Management
Department of Anaesthesia, James Paget Hospital, Great Yarmouth.

Dr Notcutt is also Honorary Senior Lecturer at the School of Health Policy and Practice at the University of East Anglia, Norwich as well as running the Pain Relief Clinic at the James Paget Hospital.

Dr Notcutt has clinical experience of the use of the synthetic Cannabinoid Nabilone for patients with chronic pain and has long experience of patient controlled analgesia, particularly that using opiates. Dr Notcutt has also written several papers and given a number of presentations on these topics.

David W. Pate, PhD, MSc

Senior Technical Officer, HortaPharm BV, Amsterdam

Dr Pate is a specialist in the botany/pharmacognosy of Cannabis and the chemistry/pharmacology of cannabinoids. Whilst employed as Senior Technical Officer at HortaPharm BV in Amsterdam he also serves as Board Secretary for the International Hemp Association and as an editor of its scientific journal. His current interests, as a researcher in the Department of Pharmaceutical Chemistry at the University of Kuopio (Finland), include the use of cannabinoids in the treatment of glaucoma.

Professor Roger Pertwee, MA, DPhil, DSc (Oxon)

Professor of Neuropharmacology, Department of Biomedical Sciences,
University of Aberdeen

Professor Pertwee is one of the world's leading researchers in cannabis and cannabinoids. His areas of research expertise are their modes of action, their pharmacology and therapeutic potential and also the physiology/pathophysiology of the endogenous cannabinoid system. Professor Pertwee is also a Former President of the International Cannabinoid Research Society (ICRS) and Chairman of the British Clinical Cannabinoid Group.

Dr Philip Robson, MB, MRCP, MRCPsych
Consultant Psychiatrist, Warneford Hospital, Oxford Senior Clinical Lecturer, University of Oxford.

Dr Robson runs the Regional Drug Dependence Unit in Oxford, which he set up in 1990. Dr Robson is well respected for his experience in the area of drug use and in 1996 was commissioned by the UK Department of Health to conduct a critical review of the scientific literature on the therapeutic uses of cannabis and cannabinoids.

Dr Robson is also the author of several publications on the use of cannabis, amphetamines, cocaine, heroin and on opiate dependence.

Ethan Russo, MD

Department of Neurosciences, Western Montana Clinic.

Dr Russo is a board-certified child and adult neurologist in Missoula, Montana where he has practiced for 16 years. He also holds faculty positions as Clinical Assistant Professor in the Department of Internal Medicine at the University of Washington and Adjunct Associate Professor in the Department of Pharmaceutical Sciences at the University of Montana. Dr. Russo pursues herbal and ethnobotanical research and is the author of numerous papers and the soon to be published "Handbook of Psychotropic Herbs". He is also Editor of the "Journal of Cannabis Therapeutics".